Company / Current Assets per Share
Veracyte, Inc. Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$6.28
FY2025
5-year range
$3.50 / $6.28
FY2021-FY2025
Trend
+23.6%
vs FY2024
Sector context
#122 of 163
Health Care
What the data says
Veracyte, Inc.'s current assets per share of $6.28 is lower than 75% of companies in the Health Care sector (FY2025). Current Assets per Share has increased for 3 consecutive years, from $3.50 in FY2022 to $6.28 in FY2025.
Based on SEC 10-K filings.
6.28 in FY2025 with a 5-year CAGR of -3.7%.
Improved from $3.97 to $6.28 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +21.6%
- 5-Year CAGR
- -3.7%
- 10-Year CAGR
- -
Sector benchmark
Bottom 25% in Health CareTop 75% of 163This company $6.28 Sector average $52.97
▼
-88.1% below sector average
Key checks
Key Insights
- Veracyte, Inc.'s current assets per share has grown for 3 consecutive years.
- In FY2025, current assets per share increased 23.6% year-over-year.
- Ranks #122 out of 163 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 6.19 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.28 | +23.6% |
| FY2024 | $5.08 | +28.0% |
| FY2023 | $3.97 | +13.5% |
| FY2022 | $3.50 | -16.3% |
| FY2021 | $4.18 | -44.8% |
| FY2020 | $7.57 | +64.8% |
| FY2019 | $4.59 | +59.9% |
| FY2018 | $2.87 | +79.8% |
| FY2017 | $1.60 | -39.9% |
| FY2016 | $2.66 | +25.0% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026